Stock listing
LUCD Stock Price, News, Filings & Events — Lucid Diagnostics Inc.
Selected listing: LUCD · BOATS · USD · US
This page tracks Lucid Diagnostics Inc.'s LUCD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LUCD:BOATS. LUCD:BOATS is the stock-level entry point for investors researching Lucid Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lucid Diagnostics Inc. is a public company traded under the ticker LUCD in the American market. The company has a market capitalization of approximately $184.3 million. Lucid Diagnostics focuses on developing innovative diagnostic solutions.
- Ticker
- LUCD:BOATS
- Asset type
- Stock
- Market cap
- $201.5M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BOATS
- Currency
- USD
Lucid Diagnostics Inc. LUCD:BOATS stock context
This page tracks Lucid Diagnostics Inc.'s LUCD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LUCD:BOATS. LUCD:BOATS is the stock-level entry point for investors researching Lucid Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lucid Diagnostics Inc. is a public company traded under the ticker LUCD in the American market. The company has a market capitalization of approximately $184.3 million. Lucid Diagnostics focuses on developing innovative diagnostic solutions.
Latest news from Lucid Diagnostics Inc.
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 13, 2026
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
August 5, 2026
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
July 30, 2026
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
May 14, 2026
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
April 30, 2026
Lucid Diagnostics Inc. earnings calls
Lucid Diagnostics Inc. (LUCD) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Lucid Diagnostics Inc. (LUCD) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Lucid Diagnostics Inc.
Lucid Diagnostics Inc. investor report
Review AI stock analysis and investor report context for LUCD:BOATS.
Lucid Diagnostics Inc. company profile
View the public company page for Lucid Diagnostics Inc. on 6ix.
Lucid Diagnostics Inc. news
Read company news and market updates connected to Lucid Diagnostics Inc..
Lucid Diagnostics Inc. investor events
Find investor webinars, events, and replay context for Lucid Diagnostics Inc..